Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfamerazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | FASN | P49327 | 1/20 | 0.67 |
| ▸ | AURKA | O14965 | 1/20 | 0.67 |
| ▸ | DHFR | P00374 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfamerazine SCHEMBL29538415 | 1.00 | MAPT (1.00) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL93591 | 0.98 | MAPT (0.97) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL5871007 | 0.98 | MAPT (0.97) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL28028780 | 0.97 | MAPT (0.94) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL8159446 | 0.96 | MAPT (0.92) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamethazine SCHEMBL4231556 | 0.94 | MAPT (0.89) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL28859835 | 0.94 | MAPT (0.89) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL28086386 | 0.94 | MAPT (0.89) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamethazine SCHEMBL30306297 | 0.91 | MAPT (0.82) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 | |
| Sulfamerazine SCHEMBL10619389 | 0.90 | MAPT (0.81) | MAPTCYP2C9NPSR1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5581 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| US-20260035351-A1 | SYNTHETIC METHOD OF SULFAMERAZINE | NANHAI BEISHA PHARMACEUTICAL CO LTD (CN) | 2026-02-05 | — | — | US | claimed |
| US-20250185632-A1 | CONTINUOUS IN-SITU THERAPEUTIC TREATMENT SYSTEM FOR FISH IN FRESHWATER, FROM SEAWATER | Salmoclinic Spa (CL) | 2025-06-12 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| CN-120044159-A | Polygonatum sibiricum medicinal material species identification method based on polygonatum sibiricum characteristic compound and application | 河北北方学院 | 2025-05-27 | — | — | CN | claimed |
| EP-4536217-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | Fleurir Abx LLC (US) | 2025-04-16 | — | — | EP | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| US-20250099557-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| US-20240335390-A9 | PHARMACEUTICAL COMPOSITIONS OF AMORPHOUS SOLID DISPERSIONS AND METHODS OF PREPARATION THEREOF | SHENZHEN PHARMACIN CO LTD (CN) | 2024-10-10 | — | — | US | claimed |
| US-4594246-A | Antibiotics | LEO PHARMACEUTICAL PRODUCTS (DK) | 1986-06-10 | — | — | US | claimed |
| US-4532245-A | Pharmaceutical compositions | HOFFMANN-LA ROCHE INC. (US) | 1985-07-30 | — | — | US | claimed |
| EP-0080341-A2 | Pharmaceutical multiple-units formulation | A/S Alfred Benzon (DK) | 1983-06-01 | — | — | EP | claimed |
| US-4315931-A | MICROBIOCIDES, INFECTIOUS DISEASES | BASF AKTIENGESELLSCHAFT (DE) | 1982-02-16 | — | — | US | claimed |
| EP-0043055-A1 | Combinations of therapeutically active substances, process for their manufacture and their use and means containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1982-01-06 | — | — | EP | claimed |
| US-4169763-A | OF A CORYNEBACTERIA RESISTANT TO ASPARTIC ACID ANALOGS AND SULFA DRUGS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1979-10-02 | — | — | US | claimed |
| US-4094976-A | ANTICOCCIDIAL CYCLICAMINO ETHANOLS AND ESTERS THEREOF | MERCK & CO., INC. (US) | 1978-06-13 | — | — | US | claimed |
| US-4087528-A | POTENTIATORS OF ANTIBACTERIAL SULFA DRUGS | ABBOTT LABORATORIES (US) | 1978-05-02 | — | — | US | claimed |
| US-4016251-A | Vaginal drug dispensing device | ALZA CORPORATION (US) | 1977-04-05 | — | — | US | claimed |
| US-3969188-A | Method of producing guanosine by fermentation | AJINOMOTO CO., INC. (JA) | 1976-07-13 | — | — | US | claimed |